153 related articles for article (PubMed ID: 30630402)
1. Rates and Determinants of Use of Pharmacotherapy and Psychotherapy by Patients With Major Depressive Disorder.
Gaspar FW; Zaidel CS; Dewa CS
Psychiatr Serv; 2019 Apr; 70(4):262-270. PubMed ID: 30630402
[TBL] [Abstract][Full Text] [Related]
2. The influence of antidepressant and psychotherapy treatment adherence on future work leaves for patients with major depressive disorder.
Gaspar FW; Wizner K; Morrison J; Dewa CS
BMC Psychiatry; 2020 Jun; 20(1):320. PubMed ID: 32560678
[TBL] [Abstract][Full Text] [Related]
3. Psychotherapy and pharmacotherapy in depression.
Powers RH; Kniesner TJ; Croghan TW
J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
[TBL] [Abstract][Full Text] [Related]
4. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis.
Gauthier G; Guérin A; Zhdanava M; Jacobson W; Nomikos G; Merikle E; François C; Perez V
BMC Psychiatry; 2017 Jun; 17(1):222. PubMed ID: 28629442
[TBL] [Abstract][Full Text] [Related]
6. Major depression treatment in Germany-descriptive analysis of health insurance fund routine data and assessment of guideline-adherence.
Wiegand HF; Sievers C; Schillinger M; Godemann F
J Affect Disord; 2016 Jan; 189():246-53. PubMed ID: 26454184
[TBL] [Abstract][Full Text] [Related]
7. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with changes in antidepressant treatment in a managed care population with major depressive disorder.
Schultz J; Joish V
Psychiatr Serv; 2009 Dec; 60(12):1604-11. PubMed ID: 19952150
[TBL] [Abstract][Full Text] [Related]
9. Continuity is the main challenge in treating major depressive disorder in psychiatric care.
Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
J Clin Psychiatry; 2005 Feb; 66(2):220-7. PubMed ID: 15705008
[TBL] [Abstract][Full Text] [Related]
10. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
[TBL] [Abstract][Full Text] [Related]
11. Adherence to augmentation therapy for the treatment of major depressive disorder.
Forma F; Liberman JN; Rui P; Ruetsch C
Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):327-335. PubMed ID: 36697398
[TBL] [Abstract][Full Text] [Related]
12. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
13. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.
Maina G; Rosso G; Bogetto F
J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001
[TBL] [Abstract][Full Text] [Related]
14. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
[TBL] [Abstract][Full Text] [Related]
15. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.
Guidi J; Tomba E; Fava GA
Am J Psychiatry; 2016 Feb; 173(2):128-37. PubMed ID: 26481173
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
17. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
Jakobsen JC
Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
[TBL] [Abstract][Full Text] [Related]
18. Receipt of Evidence-Based Pharmacotherapy and Psychotherapy Among Children and Adolescents With New Diagnoses of Depression.
Soria-Saucedo R; Walter HJ; Cabral H; England MJ; Kazis LE
Psychiatr Serv; 2016 Mar; 67(3):316-23. PubMed ID: 26725295
[TBL] [Abstract][Full Text] [Related]
19. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions.
Casacalenda N; Perry JC; Looper K
Am J Psychiatry; 2002 Aug; 159(8):1354-60. PubMed ID: 12153828
[TBL] [Abstract][Full Text] [Related]
20. Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database.
Furukawa TA; Onishi Y; Hinotsu S; Tajika A; Takeshima N; Shinohara K; Ogawa Y; Hayasaka Y; Kawakami K
J Affect Disord; 2013 Sep; 150(3):916-22. PubMed ID: 23721923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
